[1] A.S. Krolewski, Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes, Diabetes Care, 38 (2015) 954-962.
[2] A.S. Krolewski, J. Skupien, P. Rossing, J.H. Warram, Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes, Kidney Int, 91 (2017) 1300-1311.
[3] M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature, 414 (2001) 813-820.
[4] M. Brownlee, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54 (2005) 1615-1625.
[5] K.E. White, R.W. Bilous, S.M. Marshall, M. El Nahas, G. Remuzzi, G. Piras, S. De Cosmo, G. Viberti, Podocyte number in normotensive type 1 diabetic patients with albuminuria, Diabetes, 51 (2002) 3083-3089.
[6] M.E. Pagtalunan, P.L. Miller, S. Jumping-Eagle, R.G. Nelson, B.D. Myers, H.G. Rennke, N.S. Coplon, L. Sun, T.W. Meyer, Podocyte loss and progressive glomerular injury in type II diabetes, J Clin Invest, 99 (1997) 342-348.
[7] N. Jourde-Chiche, F. Fakhouri, L. Dou, J. Bellien, S. Burtey, M. Frimat, P.A. Jarrot,G. Kaplanski, M. Le Quintrec, V. Pernin, C. Rigothier, M. Sallée, V. Fremeaux-Bacchi,D. Guerrot, L.T. Roumenina, Endothelium structure and function in kidney health and disease, Nat Rev Nephrol, 15 (2019) 87-108.
[8] T.J. Rabelink, D. de Zeeuw, The glycocalyx--linking albuminuria with renal and cardiovascular disease, Nat Rev Nephrol, 11 (2015) 667-676.
[9] B.M. van den Berg, G. Wang, M.G.S. Boels, M.C. Avramut, E. Jansen, W.M.P.J. Sol,F. Lebrin, A.J. van Zonneveld, E.J.P. de Koning, H. Vink, H.J. Gröne, P. Carmeliet, J. van der Vlag, T.J. Rabelink, Glomerular Function and Structural Integrity Depend on Hyaluronan Synthesis by Glomerular Endothelium, J Am Soc Nephrol, 30 (2019) 1886- 1897.
[10] K. Yamahara, S. Kume, D. Koya, Y. Tanaka, Y. Morita, M. Chin-Kanasaki, H. Araki,K. Isshiki, S. Araki, M. Haneda, T. Matsusaka, A. Kashiwagi, H. Maegawa, T. Uzu, Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions, J Am Soc Nephrol, 24 (2013) 1769-1781.
[11] A. Kamijo, K. Kimura, T. Sugaya, M. Yamanouchi, H. Hase, T. Kaneko, Y. Hirata,A. Goto, T. Fujita, M. Omata, Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage, Kidney Int, 62 (2002) 1628-1637.
[12] M. Yoshibayashi, S. Kume, M. Yasuda-Yamahara, K. Yamahara, N. Takeda, N. Osawa, M. Chin-Kanasaki, Y. Nakae, H. Yokoi, M. Mukoyama, K. Asanuma, H. Maegawa, S.I. Araki, Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes, Biochem Biophys Res Commun, 525 (2020) 319- 325.
[13] S. Agrawal, A.J. Guess, M.A. Chanley, W.E. Smoyer, Albumin-induced podocyte injury and protection are associated with regulation of COX-2, Kidney Int, 86 (2014) 1150-1160.
[14] F. He, S. Chen, H. Wang, N. Shao, X. Tian, H. Jiang, J. Liu, Z. Zhu, X. Meng, C. Zhang, Regulation of CD2-associated protein influences podocyte endoplasmic reticulum stress-mediated apoptosis induced by albumin overload, Gene, 484 (2011) 18-25.
[15] K. Okamura, P. Dummer, J. Kopp, L. Qiu, M. Levi, S. Faubel, J. Blaine, Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death, PLoS One, 8 (2013) e54817.
[16] N. Mizushima, B. Levine, Autophagy in Human Diseases, N Engl J Med, 383 (2020) 1564-1576.
[17] N. Mizushima, M. Komatsu, Autophagy: renovation of cells and tissues, Cell, 147 (2011) 728-741.
[18] S. Ueda, S. Ozawa, K. Mori, K. Asanuma, M. Yanagita, S. Uchida, T. Nakagawa, ENOS deficiency causes podocyte injury with mitochondrial abnormality, Free Radic Biol Med, 87 (2015) 181-192.
[19] J. Su, D. Ye, C. Gao, Q. Huang, D. Gui, Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury, Mol Biol Rep, 47 (2020) 8023-8035.
[20] H. Otera, N. Ishihara, K. Mihara, New insights into the function and regulation of mitochondrial fission, Biochim Biophys Acta, 1833 (2013) 1256-1268.
[21] L. Wang, T. Ishihara, Y. Ibayashi, K. Tatsushima, D. Setoyama, Y. Hanada, Y. Takeichi, S. Sakamoto, S. Yokota, K. Mihara, D. Kang, N. Ishihara, R. Takayanagi, M. Nomura, Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration, Diabetologia, 58 (2015) 2371-2380.
[22] T.G. Hennings, D.G. Chopra, E.R. DeLeon, H.R. VanDeusen, H. Sesaki, M.J. Merrins, G.M. Ku, In Vivo Deletion of β-Cell Drp1 Impairs Insulin Secretion Without Affecting Islet Oxygen Consumption, Endocrinology, 159 (2018) 3245-3256.
[23] F.C. Brosius, C.E. Alpers, E.P. Bottinger, M.D. Breyer, T.M. Coffman, S.B. Gurley,R.C. Harris, M. Kakoki, M. Kretzler, E.H. Leiter, M. Levi, R.A. McIndoe, K. Sharma, O. Smithies, K. Susztak, N. Takahashi, T. Takahashi, A.M.o.D.C. Consortium, Mouse models of diabetic nephropathy, J Am Soc Nephrol, 20 (2009) 2503-2512.
[24] A.H. Salmon, J.K. Ferguson, J.L. Burford, H. Gevorgyan, D. Nakano, S.J. Harper,D.O. Bates, J. Peti-Peterdi, Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction, J Am Soc Nephrol, 23 (2012) 1339-1350.
[25] K.B. Betteridge, K.P. Arkill, C.R. Neal, S.J. Harper, R.R. Foster, S.C. Satchell, D.O. Bates, A.H.J. Salmon, Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function, J Physiol, 595 (2017) 5015-5035.
[26] N. Ishihara, M. Nomura, A. Jofuku, H. Kato, S.O. Suzuki, K. Masuda, H. Otera, Y. Nakanishi, I. Nonaka, Y. Goto, N. Taguchi, H. Morinaga, M. Maeda, R. Takayanagi, S. Yokota, K. Mihara, Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice, Nat Cell Biol, 11 (2009) 958-966.
[27] H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, K. Kuwahara, J. Fujikura, Y. Arai,Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao, Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice, Nephrol Dial Transplant, 25 (2010) 2120-2124.
[28] S. Ono, S. Kume, M. Yasuda-Yamahara, K. Yamahara, N. Takeda, M. Chin-Kanasaki,H. Araki, O. Sekine, H. Yokoi, M. Mukoyama, T. Uzu, S.I. Araki, H. Maegawa, O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes, Nephrol Dial Transplant, 32 (2017) 1477-1487.
[29] M.A. Saleem, M.J. O'Hare, J. Reiser, R.J. Coward, C.D. Inward, T. Farren, C.Y. Xing,L. Ni, P.W. Mathieson, P. Mundel, A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression, J Am Soc Nephrol, 13 (2002) 630-638.
[30] M. Yasuda, Y. Tanaka, S. Kume, Y. Morita, M. Chin-Kanasaki, H. Araki, K. Isshiki,S. Araki, D. Koya, M. Haneda, A. Kashiwagi, H. Maegawa, T. Uzu, Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes, Biochim Biophys Acta, 1842 (2014) 1097-1108.
[31] S. Kume, M. Haneda, K. Kanasaki, T. Sugimoto, S. Araki, K. Isshiki, M. Isono, T. Uzu, L. Guarente, A. Kashiwagi, D. Koya, SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation, J Biol Chem, 282 (2007) 151-158.
[32] C. Schell, B. Sabass, M. Helmstaedter, F. Geist, A. Abed, M. Yasuda-Yamahara, A. Sigle, J.I. Maier, F. Grahammer, F. Siegerist, N. Artelt, N. Endlich, D. Kerjaschki, H.H. Arnold, J. Dengjel, M. Rogg, T.B. Huber, ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier, Dev Cell, 47 (2018) 741-757.e748.
[33] K. Katsuya, E. Yaoita, Y. Yoshida, Y. Yamamoto, T. Yamamoto, An improved method for primary culture of rat podocytes, Kidney Int, 69 (2006) 2101-2106.
[34] W. Wang, Y. Wang, J. Long, J. Wang, S.B. Haudek, P. Overbeek, B.H. Chang, P.T. Schumacker, F.R. Danesh, Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells, Cell Metab, 15 (2012) 186-200.
[35] B.A. Ayanga, S.S. Badal, Y. Wang, D.L. Galvan, B.H. Chang, P.T. Schumacker, F.R. Danesh, Dynamin-Related Protein 1 Deficiency Improves Mitochondrial Fitness and Protects against Progression of Diabetic Nephropathy, J Am Soc Nephrol, 27 (2016) 2733-2747.
[36] D.L. Galvan, J. Long, N. Green, B.H. Chang, J.S. Lin, P. Schumacker, L.D. Truong,P. Overbeek, F.R. Danesh, Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice, J Clin Invest, 129 (2019) 2807-2823.
[37] Y. Ma, Z. Chen, Y. Tao, J. Zhu, H. Yang, W. Liang, G. Ding, Increased mitochondrial fission of glomerular podocytes in diabetic nephropathy, Endocr Connect, 8 (2019) 1206- 1212.
[38] S. Maeda, Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP, Diabetes Res Clin Pract, 66 Suppl 1 (2004) S45-47.
[39] L. Zhang, X. Gan, Y. He, Z. Zhu, J. Zhu, H. Yu, Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species, PLoS One, 12 (2017) e0175262.
[40] D.B. Wang, G.A. Garden, C. Kinoshita, C. Wyles, N. Babazadeh, B. Sopher, Y. Kinoshita, R.S. Morrison, Declines in Drp1 and parkin expression underlie DNA damage- induced changes in mitochondrial length and neuronal death, J Neurosci, 33 (2013) 1357- 1365.
[41] J. Liu, Z. Chen, Y. Zhang, M. Zhang, X. Zhu, Y. Fan, S. Shi, K. Zen, Z. Liu, Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia, Diabetes, 62 (2013) 3927-3935.
[42] A. Ferreira-da-Silva, C. Valacca, E. Rios, H. Pópulo, P. Soares, M. Sobrinho-Simões,L. Scorrano, V. Máximo, S. Campello, Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration, PLoS One, 10 (2015) e0122308.
[43] L. Wang, X. Li, Y. Hanada, N. Hasuzawa, Y. Moriyama, M. Nomura, K. Yamamoto, Dynamin-related protein 1 deficiency accelerates lipopolysaccharide-induced acute liver injury and inflammation in mice, Commun Biol, 4 (2021) 894.